{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:14:29Z","timestamp":1793319269506,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4ts-Herzzentrum Freiburg - Bad Krozingen GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-procedural complications after transfemoral transcatheter aortic valve implantation (TF-TAVI) lead to extended healthcare resource consumption. A comparison with resource consumption after surgical aortic stenosis valve replacement (SAVR) complications has not been conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The impact of acute kidney injury (AKI), stroke, severe bleeding and permanent pacemaker implantation (PPI) on length of stay, mechanical ventilation\u2009&gt;\u200948\u00a0h and reimbursement was analyzed by risk-adjusted linear and logistic regression analyses of all German aortic stenosis TF-TAVI and SAVR cases 2021\/2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>48,565 TF-TAVI and 9,803 SAVR procedures for aortic stenosis treatment were performed in Germany 2021\/2022. The length of stay for TF-TAVI was shorter (10.16\u2009\u00b1\u20097.19 vs. 13.91\u2009\u00b1\u20099.82\u00a0days, p\u2009&lt;\u20090.001), the rate of mechanical ventilation\u2009&gt;\u200948\u00a0h was lower after TF-TAVI (1.3% vs. 7.0%, p\u2009&lt;\u20090.001) and reimbursement was higher for TF-TAVI (26,483\u2009\u00b1\u20094,487 vs. 20,538\u2009\u00b1\u200911,748\u00a0\u20ac, p\u2009&lt;\u20090.001). Length of stay was increased by all investigated complications after TF-TAVI and SAVR (p\u2009&lt;\u20090.001) with the highest increase after bleeding in TF-TAVI. Odds ratios for mechanical ventilation\u2009&gt;\u200948\u00a0h were significantly increased for stroke, severe bleeding and AKI (p\u2009&lt;\u20090.001) but not for PPI after both TF-TAVI and SAVR with the highest OR increase after bleeding in TF-TAVI. Reimbursement was significantly increased after TF-TAVI and SAVR by all investigated complications (p\u2009&lt;\u20090.001) finding significantly higher increases after SAVR compared to TF-TAVI for all complications.<\/jats:p>\n                    <jats:p>The total hospital stay after stroke, AKI and PPM was longer for SAVR (p\u2009&lt;\u20090.001), while severe bleeding led to longer total hospital stay after TF-TAVI (p\u2009&lt;\u20090.001). Total reimbursement remained higher for TF-TAVI after all investigated complications (p\u2009&lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Healthcare resource consumption differs between TF-TAVI and SAVR for aortic stenosis treatment also after procedural complications. SAVR is associated with longer hospitalization and more mechanical ventilation, while TF-TAVI is associated with higher reimbursement in the German healthcare system. Complications lead to increased resource use for both procedures with higher extra reimbursement for SAVR and more extra hospital days for TF-TAVI after bleeding reversing the length of stay advantage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10198-025-01838-8","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:17:30Z","timestamp":1760440650000},"page":"651-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TF-TAVI and SAVR post-procedural complications in Germany 2021\/2022 \u2013 impact on healthcare resource consumption"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-7495","authenticated-orcid":false,"given":"Alexander","family":"Maier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Zientara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"J\u00e4ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rilinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Oettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas A.","family":"Heger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Gottardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Czerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"von zur M\u00fchlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1838_CR1","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1161\/CIR.0000000000001258","volume":"150","author":"DS Kazi","year":"2024","unstructured":"Kazi, D.S., et al.: Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: a presidential advisory from the American Heart Association. Circulation 150, e89\u2013e101 (2024)","journal-title":"Circulation"},{"key":"1838_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","volume":"18","author":"S Coffey","year":"2021","unstructured":"Coffey, S., et al.: Global epidemiology of valvular heart disease. Nat. Rev. Cardiol. 18, 853\u2013864 (2021)","journal-title":"Nat. Rev. Cardiol."},{"key":"1838_CR3","first-page":"e46535","volume":"15","author":"J Kermanshahchi","year":"2023","unstructured":"Kermanshahchi, J., et al.: A review of the cost effectiveness of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR). Cureus 15, e46535 (2023)","journal-title":"Cureus"},{"key":"1838_CR4","volume":"16","author":"J Kermanshahchi","year":"2024","unstructured":"Kermanshahchi, J., et al.: Transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR): a review on the length of stay, cost, comorbidities, and procedural complications. Cureus 16, e54435 (2024)","journal-title":"Cureus"},{"key":"1838_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian, A., et al.: 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561\u2013632 (2022)","journal-title":"Eur. Heart J."},{"key":"1838_CR6","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1016\/j.jacc.2012.09.018","volume":"60","author":"MR Reynolds","year":"2012","unstructured":"Reynolds, M.R., et al.: Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J. Am. Coll. Cardiol. 60, 2683\u20132692 (2012)","journal-title":"J. Am. Coll. Cardiol."},{"key":"1838_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacc.2015.10.046","volume":"67","author":"MR Reynolds","year":"2016","unstructured":"Reynolds, M.R., et al.: Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J. Am. Coll. Cardiol. 67, 29\u201338 (2016)","journal-title":"J. Am. Coll. Cardiol."},{"key":"1838_CR8","doi-asserted-by":"publisher","first-page":"e953","DOI":"10.4244\/EIJV15I11A179","volume":"15","author":"BZ Galper","year":"2019","unstructured":"Galper, B.Z., Baron, S.J., Cohen, D.J.: Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION? EuroIntervention 15, e953\u2013e955 (2019)","journal-title":"EuroIntervention"},{"key":"1838_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011295","volume":"15","author":"SJ Baron","year":"2022","unstructured":"Baron, S.J., Ryan, M.P., Moore, K.A., Clancy, S.J., Gunnarsson, C.L.: Contemporary costs associated with transcatheter versus surgical aortic valve replacement in Medicare beneficiaries. Circ. Cardiovasc. Interv. 15, e011295 (2022)","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1838_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10198-017-0877-7","volume":"19","author":"K Kaier","year":"2018","unstructured":"Kaier, K., et al.: The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany. Eur. J. Health Econ. 19, 223\u2013228 (2018)","journal-title":"Eur. J. Health Econ."},{"key":"1838_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcin.2018.12.019","volume":"12","author":"E Grube","year":"2019","unstructured":"Grube, E., Sinning, J.-M.: The \u2018Big Five\u2019 Complications After Transcatheter Aortic Valve Replacement: Do We Still Have to Be Afraid of Them? JACC Cardiovasc. Interv. 12, 370\u2013372 (2019)","journal-title":"JACC Cardiovasc. Interv."},{"key":"1838_CR12","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMoa1500893","volume":"373","author":"J Rein\u00f6hl","year":"2015","unstructured":"Rein\u00f6hl, J., et al.: Effect of availability of transcatheter aortic-valve replacement on clinical practice. N. Engl. J. Med 373, 2438\u20132447 (2015)","journal-title":"N. Engl. J. Med"},{"key":"1838_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00392-023-02326-w","volume":"113","author":"V Oettinger","year":"2024","unstructured":"Oettinger, V., et al.: Comparing balloon-expandable and self-expanding transfemoral transcatheter aortic valve replacement based on subgroups in Germany 2019\/2020. Clin. Res. Cardiol. 113, 168\u2013176 (2024)","journal-title":"Clin. Res. Cardiol."},{"key":"1838_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02538-8","author":"A Maier","year":"2024","unstructured":"Maier, A., et al.: Procedural safety of rotational atherectomy and modified balloon angioplasty: insights from a German national registry. Clin. Res. Cardiol. (2024). https:\/\/doi.org\/10.1007\/s00392-024-02538-8","journal-title":"Clin. Res. Cardiol."},{"key":"1838_CR15","first-page":"1419","volume":"113","author":"A Maier","year":"2024","unstructured":"Maier, A., et al.: Catheter based left atrial appendage closure in-hospital outcomes in Germany from 2016 to 2020. Clin. Res. Cardiol. 113, 1419\u20131429 (2024)","journal-title":"Clin. Res. Cardiol."},{"key":"1838_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10198-018-1023-x","volume":"20","author":"K Kaier","year":"2019","unstructured":"Kaier, K., et al.: Estimating the additional costs per life saved due to transcatheter aortic valve replacement: a secondary data analysis of electronic health records in Germany. Eur. J. Health Econ. 20, 625\u2013632 (2019)","journal-title":"Eur. J. Health Econ."},{"key":"1838_CR17","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJMoa2307447","volume":"389","author":"MJ Mack","year":"2023","unstructured":"Mack, M.J., et al.: Transcatheter aortic-valve replacement in low-risk patients at five years. N. Engl. J. Med. 389, 1949\u20131960 (2023)","journal-title":"N. Engl. J. Med."},{"key":"1838_CR18","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jtcvs.2020.02.078","volume":"162","author":"P Stachon","year":"2021","unstructured":"Stachon, P., et al.: Transapical aortic valve replacement versus surgical aortic valve replacement: A subgroup analyses for at-risk populations. The Journal of Thoracic and Cardiovascular Surgery 162, 1701-1709.e1 (2021)","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"key":"1838_CR19","first-page":"992","volume":"34","author":"K Kaier","year":"2018","unstructured":"Kaier, K., et al.: Sex-specific differences in outcome of transcatheter or surgical aortic valve replacement. Can. J. Cardiol. 34, 992\u2013998 (2018)","journal-title":"Can. J. Cardiol."},{"key":"1838_CR20","unstructured":"GKV-Spitzenverband. Bundesbasisfallwert (BBFW). https:\/\/www.gkv-spitzenverband.de\/krankenversicherung\/krankenhaeuser\/budgetverhandlungen\/bundesbasisfallwert\/bundesbasisfallwert.jsp. Accessed 10 Sept 2025"},{"key":"1838_CR21","unstructured":"DRG F98B | Erl\u00f6s und Pflegeentgelt | Gebietsanalysen | CMI. https:\/\/app.reimbursement.info\/drgs\/F98B?year=2022. Accessed 10 Sept 2025"},{"key":"1838_CR22","unstructured":"DRG F98B | Erl\u00f6s und Pflegeentgelt | Gebietsanalysen | CMI. https:\/\/app.reimbursement.info\/drgs\/F98B?year=2014. Accessed 10 Sept 2025"},{"key":"1838_CR23","unstructured":"DRG F03D | Erl\u00f6s und Pflegeentgelt | Gebietsanalysen | CMI. https:\/\/app.reimbursement.info\/drgs\/F03D?year=2014. Accessed 10 Sept 2025"},{"key":"1838_CR24","unstructured":"DRG F03D | Erl\u00f6s und Pflegeentgelt | Gebietsanalysen | CMI. https:\/\/app.reimbursement.info\/drgs\/F03D?year=2022. Accessed 10 Sept 2025"},{"key":"1838_CR25","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/S0140-6736(24)00821-3","volume":"403","author":"A Baumbach","year":"2024","unstructured":"Baumbach, A., et al.: Landmark comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial. Lancet 403, 2695\u20132708 (2024)","journal-title":"Lancet"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-025-01838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-025-01838-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-025-01838-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:45:31Z","timestamp":1779248731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-025-01838-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1007\/s10198-025-01838-8","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}